Sex Hormones in Postmenopausal Women Receiving Low‐Dose Hormone Therapy: The Effect of BMI
Abstract
The aim of our study was to evaluate the effect of BMI on the change in circulating sex hormone in postmenopausal women during 6 months of oral continuous combined low‐dose hormone therapy (HT). Fifty postmenopausal women were allocated to receive daily one tablet containing combination of 17β‐estradiol (1 mg)/norethindrone acetate (0.5 mg) for 6 months. Serum levels of follicle‐stimulating hormone (FSH), estradiol, total testosterone, sex hormone‐binding globulin (SHBG), free androgen index (FAI), free estrogen index (FEI), Δ4‐androstendione (Δ4A), and dehydroepiandrosterone sulfate were assessed at baseline and at the end of 6 months. Mean absolute values and percent changes from baseline were compared between lean and overweight women. Mean FSH decreased and mean 17β‐estradiol increased significantly in both groups (FSH lean: 82.3 ± 26.7 decreased to 45.0 ± 17.0 mIU/ml, P = 0.0001; FSH overweight: 85.5 ± 22.1 decreased to 52.3 ± 23.8 mIU/ml, P = 0.003; P between groups = 0.661; E2 lean: 23.24 ± 12.55 increased to 53.62 ± 28.29 pg/ml, P = 0.006; E2 overweight: 24.17 ± 10.88 increased to 68.36 ± 53.99 pg/ml, P = 0.0001; P between groups = 0.619). Lean individuals had statistically significant higher increments of FAI and specifically FEI compared to overweight (FEI lean; 0.14 ± 0.09 increased to 0.29 ± 0.14, P = 0.009; overweight 0.23 ± 0.18 increased to 0.52 ± 0.40, P = 0.126; P between groups = 0.034). Although BMI does not affect total 17β‐estradiol changes, free sex steroid concentrations increase more steeply in lean compared to overweight women receiving oral low‐dose HT.Keywords
This publication has 32 references indexed in Scilit:
- Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Influence of Age and Obesity on Serum Estradiol, Estrone, and Sex Hormone Binding Globulin Concentrations following Oral Estrogen Administration in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2009
- PSA and body composition by dual X‐Ray absorptiometry (DXA) in NHANESThe Prostate, 2009
- Relationship between Serum Levels of Sex Hormones and Progression of Subclinical Atherosclerosis in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2008
- Benefits of hormone replacement therapy in postmenopausal womenJournal of the American Academy of Nurse Practitioners, 2007
- Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal womenDiabetes, Obesity and Metabolism, 2005
- The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal womenBone, 2004
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997